Getinge Past Earnings Performance
Past criteria checks 2/6
Getinge has been growing earnings at an average annual rate of 1.8%, while the Medical Equipment industry saw earnings growing at 21.2% annually. Revenues have been growing at an average rate of 3.7% per year. Getinge's return on equity is 5.6%, and it has net margins of 5%.
Key information
1.8%
Earnings growth rate
1.8%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 3.7% |
| Return on equity | 5.6% |
| Net Margin | 5.0% |
| Next Earnings Update | 28 Jan 2025 |
Recent past performance updates
Recent updates
Getinge (STO:GETI B) Is Experiencing Growth In Returns On Capital
Oct 17
Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued
Aug 08Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 21We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)
Jun 27Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly
May 11Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Apr 25Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?
Apr 15The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 30Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Mar 29The Return Trends At Getinge (STO:GETI B) Look Promising
Mar 21Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results
Feb 04There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price
Jan 20Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Jan 05Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price
Dec 20Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)
Dec 05Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 06Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?
Sep 21Getinge's (STO:GETI B) Returns On Capital Are Heading Higher
Sep 03Is Getinge (STO:GETI B) A Risky Investment?
Jun 28Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?
Jun 15Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist
Jun 01At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?
May 05Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25
Apr 05Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement
Feb 28Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?
Feb 16Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year
Feb 04Is Getinge (STO:GETI B) Using Too Much Debt?
Feb 03When Should You Buy Getinge AB (publ) (STO:GETI B)?
Jan 07Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?
Nov 06Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 07We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt
Jun 25Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Getinge makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 33,591 | 1,691 | 10,342 | 1,330 |
| 30 Jun 24 | 33,328 | 2,584 | 10,235 | 1,292 |
| 31 Mar 24 | 32,199 | 2,285 | 9,956 | 1,207 |
| 31 Dec 23 | 31,827 | 2,412 | 9,681 | 1,192 |
| 30 Sep 23 | 30,423 | 2,251 | 9,260 | 1,258 |
| 30 Jun 23 | 29,756 | 2,154 | 9,004 | 1,232 |
| 31 Mar 23 | 29,251 | 2,543 | 8,672 | 1,228 |
| 31 Dec 22 | 28,292 | 2,491 | 8,386 | 1,185 |
| 30 Sep 22 | 27,781 | 2,707 | 8,240 | 1,008 |
| 30 Jun 22 | 27,146 | 2,665 | 8,060 | 952 |
| 31 Mar 22 | 27,062 | 2,860 | 8,005 | 903 |
| 31 Dec 21 | 27,049 | 2,970 | 7,927 | 851 |
| 30 Sep 21 | 27,900 | 3,292 | 8,090 | 891 |
| 30 Jun 21 | 29,571 | 3,916 | 8,221 | 899 |
| 31 Mar 21 | 29,955 | 3,612 | 8,390 | 1,035 |
| 31 Dec 20 | 29,819 | 3,239 | 8,783 | 1,033 |
| 30 Sep 20 | 29,478 | 3,050 | 8,830 | 952 |
| 30 Jun 20 | 27,738 | 1,878 | 8,958 | 920 |
| 31 Mar 20 | 27,044 | 1,487 | 9,017 | 757 |
| 31 Dec 19 | 26,559 | 1,222 | 8,854 | 762 |
| 30 Sep 19 | 25,951 | 1,030 | 8,644 | 744 |
| 30 Jun 19 | 25,398 | -632 | 8,628 | 724 |
| 31 Mar 19 | 24,852 | -654 | 8,455 | 718 |
| 31 Dec 18 | 24,172 | -967 | 8,292 | 691 |
| 30 Sep 18 | 23,653 | -727 | 8,157 | 676 |
| 30 Jun 18 | 22,914 | 847 | 7,867 | 670 |
| 31 Mar 18 | 22,552 | 676 | 7,747 | 642 |
| 31 Dec 17 | 22,495 | 1,096 | 7,740 | 594 |
| 30 Sep 17 | 17,061 | 596 | 5,858 | 504 |
| 30 Jun 17 | 19,046 | 390 | 6,360 | 496 |
| 31 Mar 17 | 20,604 | 701 | 6,783 | 500 |
| 31 Dec 16 | 22,170 | 698 | 7,201 | 538 |
| 30 Sep 16 | 29,650 | 1,203 | 9,512 | 628 |
| 30 Jun 16 | 29,646 | 1,462 | 9,561 | 624 |
| 31 Mar 16 | 29,900 | 1,410 | 9,777 | 607 |
| 31 Dec 15 | 30,235 | 1,390 | 9,905 | 598 |
| 30 Sep 15 | 29,303 | 1,429 | 9,722 | 574 |
| 30 Jun 15 | 28,603 | 1,622 | 9,471 | 574 |
| 31 Mar 15 | 27,749 | 1,850 | 9,069 | 591 |
| 31 Dec 14 | 26,669 | 1,433 | 8,596 | 597 |
| 30 Sep 14 | 25,843 | 1,672 | 8,403 | 620 |
| 30 Jun 14 | 25,468 | 1,718 | 8,180 | 620 |
| 31 Mar 14 | 25,157 | 1,776 | 8,040 | 612 |
| 31 Dec 13 | 25,287 | 2,285 | 7,962 | 619 |
Quality Earnings: GETI B has high quality earnings.
Growing Profit Margin: GETI B's current net profit margins (5%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GETI B's earnings have grown by 1.8% per year over the past 5 years.
Accelerating Growth: GETI B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GETI B had negative earnings growth (-24.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (28.2%).
Return on Equity
High ROE: GETI B's Return on Equity (5.6%) is considered low.